CEFTRIAXONE VIATRIS 500 mg/5 ml, powder and solvent for solution for injection (IV) bottle, 5 ml
Active ingredients: Ceftriaxone, Ceftriaxone sodium heptahydrate
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottle, 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEFTRIAXONE VIATRIS 500 mg/5 ml, poudre et solvant pour solution injectable (IV)
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 500 mg - 1 ampoule(s) en verre de 5 ml
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 9 Jul 2001
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60235330CIP73556755CIP133400935567550Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CEFTRIAXONE SODIQUEpoudre | 596,50 mg · un flacon de poudre | SA |
| CEFTRIAXONE BASEpoudre | 500 mg · un flacon de poudre | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.